Nubeqa™ (darolutamide) approved for additional prostate cancer indication in China
Not intended for U.S. and UK Media Berlin, March 20, 2023 – The Chinese National Medical Products Administration (NMPA) has ...
Read moreNot intended for U.S. and UK Media Berlin, March 20, 2023 – The Chinese National Medical Products Administration (NMPA) has ...
Read more© 2023 earth-news.info